FATP2/SLC27A2 Antibody (466106) [Alexa Fluor® 594] Summary
HEK293 human embryonic kidney cell line transfected with human FATP2
Met1-Leu620
Accession # O14975
Met1-Leu620
Accession # O14975
Detects human FATP2. Stains human FATP2 transfectants but not irrelevant transfectants.
IgG1
Monoclonal
Mouse
Test in a species/application not listed above to receive a full credit towards a future purchase.
Learn about the Innovators Reward
Applications/Dilutions
- Intracellular Staining by Flow Cytometry 0.25-1 ug/10^6 cells
Packaging, Storage & Formulations
Store the unopened product at 2 – 8 °C. Do not use past expiration date.
Supplied 0.2 mg/mL in a saline solution containing BSA and Sodium Azide.
Notes
This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.
Alternate Names for FATP2/SLC27A2 Antibody (466106) [Alexa Fluor® 594]
- ACSVL1
- ACSVL1FATP-2
- EC 6.2.1
- EC 6.2.1.-
- EC 6.2.1.3
- EC 6.2.1.7
- FACVL1
- FACVL1very long-chain fatty-acid-coenzyme A ligase 1
- FATP2
- FATP2THCA-CoA ligase
- Fatty acid transport protein 2
- Fatty-acid-coenzyme A ligase, very long-chain 1
- hFACVL1
- HsT17226
- Long-chain-fatty-acid–CoA ligase
- SLC27A2
- solute carrier family 27 (fatty acid transporter), member 2
- Solute carrier family 27 member 2
- THCA-CoA ligase
- very-long-chain acyl-CoA synthetase
- VLACS
- VLACSVery long-chain-fatty-acid-CoA ligase
- VLCS
- VLCSvery long-chain acyl-CoA synthetase
Background
Fatty Acid Transport Protein 2 (FATP2), also known as SLC27A2 (solute carrier family 27, member 2), is a multipass transmembrane protein that participates in the transport and metabolism of long chain fatty acids. It has acyl-CoA synthase activity and contains an AMP-binding motif. FATP2 localizes to the endoplasmic reticulum and is predominantly expressed in the liver and kidney. Human FATP2 shares 82% aa sequence identity with mouse and rat FATP2.
Limitations
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
product targets : TRP Channel inhibitors